Parambil develops reliable, high-quality software for medical record review. It leverages clinical and statistical expertise alongside advanced technology to deliver an exceptional product experience.
Parambil ensures unmatched accuracy in data analysis, thoroughly reviewing and verifying medical records and related information. This precision builds trust among plaintiffs and defense attorneys, providing precise and reliable facts.
Parambil serves various stakeholders in the legal field:
- Plaintiff Law Firms gain case insights and generate facts for resolution.
- Court Systems can audit dockets quickly with a trusted third party.
- Defense Law Firms validate plaintiff-provided responses against key evidence.
- Insurance Companies empower defense teams with easily accessible insights.
- Defendants ensure thorough reviews and understand the full scope of claims.
- Litigation Finance audits firm dockets to support meritorious claims.
Funding Information:
Parambil has raised a total of $8M in funding over 2 rounds. Their latest funding of $6M was raised in January 2026 from a Seed round lead by Bling Capital. Parambil is funded by 6 investors. Scott Stevenson and Todd Suzanski are the most recent investors. A Pre-Seed round of $2M was raised in January 2025 from Daybreak ventures.
Loading...